UniProt ID | T3JAM_HUMAN | |
---|---|---|
UniProt AC | Q9Y228 | |
Protein Name | TRAF3-interacting JNK-activating modulator | |
Gene Name | TRAF3IP3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 551 | |
Subcellular Localization |
Membrane Single-pass type IV membrane protein . |
|
Protein Description | May function as an adapter molecule that regulates TRAF3-mediated JNK activation.. | |
Protein Sequence | MISPDPRPSPGLARWAESYEAKCERRQEIRESRRCRPNVTTCRQVGKTLRIQQREQLQRARLQQFFRRRNLELEEKGKAQHPQAREQGPSRRPGQVTVLKEPLSCARRISSPREQVTGTSSEVFPAQHPPPSGICRDLSDHLSSQAGGLPPQDTPIKKPPKHHRGTQTKAEGPTIKNDASQQTNYGVAVLDKEIIQLSDYLKEALQRELVLKQKMVILQDLLSTLIQASDSSWKGQLNEDKLKGKLRSLENQLYTCTQKYSPWGMKKVLLEMEDQKNSYEQKAKESLQKVLEEKMNAEQQLQSTQRSLALAEQKCEEWRSQYEALKEDWRTLGTQHRELESQLHVLQSKLQGADSRDLQMNQALRFLENEHQQLQAKIECLQGDRDLCSLDTQDLQDQLKRSEAEKLTLVTRVQQLQGLLQNQSLQLQEQEKLLTKKDQALPVWSPKSFPNEVEPEGTGKEKDWDLRDQLQKKTLQLQAKEKECRELHSELDNLSDEYLSCLRKLQHCREELNQSQQLPPRRQCGRWLPVLMVVIAAALAVFLANKDNLMI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Phosphorylation | -----MISPDPRPSP -----CCCCCCCCCC | 23.19 | 23401153 | |
9 | Phosphorylation | ISPDPRPSPGLARWA CCCCCCCCCCHHHHH | 32.64 | 30108239 | |
78 | Ubiquitination | LELEEKGKAQHPQAR CHHHHCCCCCCCHHH | 56.81 | - | |
110 | Phosphorylation | LSCARRISSPREQVT CCCCHHCCCCCHHCC | 32.26 | 24247654 | |
111 | Phosphorylation | SCARRISSPREQVTG CCCHHCCCCCHHCCC | 26.13 | 28634298 | |
117 | Phosphorylation | SSPREQVTGTSSEVF CCCCHHCCCCCCCCC | 34.14 | 28634298 | |
119 | Phosphorylation | PREQVTGTSSEVFPA CCHHCCCCCCCCCCC | 21.51 | 28634298 | |
120 | Phosphorylation | REQVTGTSSEVFPAQ CHHCCCCCCCCCCCC | 26.33 | 28634298 | |
121 | Phosphorylation | EQVTGTSSEVFPAQH HHCCCCCCCCCCCCC | 37.30 | 28634298 | |
154 | Phosphorylation | GGLPPQDTPIKKPPK CCCCCCCCCCCCCCC | 22.97 | - | |
180 | Phosphorylation | PTIKNDASQQTNYGV CCCCCCHHHCCCCEE | 26.19 | - | |
183 | Phosphorylation | KNDASQQTNYGVAVL CCCHHHCCCCEEEEE | 23.83 | 22115753 | |
185 | Phosphorylation | DASQQTNYGVAVLDK CHHHCCCCEEEEECH | 19.16 | 22817900 | |
192 | Ubiquitination | YGVAVLDKEIIQLSD CEEEEECHHHHHHHH | 46.80 | - | |
202 | Ubiquitination | IQLSDYLKEALQREL HHHHHHHHHHHHHHH | 34.41 | - | |
254 | Phosphorylation | RSLENQLYTCTQKYS HHHHHHHHHHCHHCC | 7.04 | 22817900 | |
255 | Phosphorylation | SLENQLYTCTQKYSP HHHHHHHHHCHHCCC | 20.05 | 22115753 | |
257 | Phosphorylation | ENQLYTCTQKYSPWG HHHHHHHCHHCCCCC | 21.94 | 28122231 | |
260 | Phosphorylation | LYTCTQKYSPWGMKK HHHHCHHCCCCCHHH | 15.33 | 22817900 | |
261 | Phosphorylation | YTCTQKYSPWGMKKV HHHCHHCCCCCHHHH | 22.63 | 27080861 | |
267 | Ubiquitination | YSPWGMKKVLLEMED CCCCCHHHHHHHHHH | 29.26 | 17203973 | |
272 | Sulfoxidation | MKKVLLEMEDQKNSY HHHHHHHHHHHCCHH | 7.49 | 21406390 | |
276 | Ubiquitination | LLEMEDQKNSYEQKA HHHHHHHCCHHHHHH | 61.25 | - | |
294 | Ubiquitination | LQKVLEEKMNAEQQL HHHHHHHHCCHHHHH | 28.25 | - | |
295 | Sulfoxidation | QKVLEEKMNAEQQLQ HHHHHHHCCHHHHHH | 6.94 | 21406390 | |
314 | Ubiquitination | SLALAEQKCEEWRSQ HHHHHHHHHHHHHHH | 34.81 | - | |
320 | Phosphorylation | QKCEEWRSQYEALKE HHHHHHHHHHHHHHH | 37.88 | 22115753 | |
322 | Phosphorylation | CEEWRSQYEALKEDW HHHHHHHHHHHHHHH | 12.38 | 28796482 | |
326 | Ubiquitination | RSQYEALKEDWRTLG HHHHHHHHHHHHHHH | 61.75 | - | |
349 | Ubiquitination | QLHVLQSKLQGADSR HHHHHHHHHCCCCHH | 31.69 | - | |
349 | Acetylation | QLHVLQSKLQGADSR HHHHHHHHHCCCCHH | 31.69 | 25953088 | |
360 | Sulfoxidation | ADSRDLQMNQALRFL CCHHHHHHHHHHHHH | 5.36 | 21406390 | |
377 | Ubiquitination | EHQQLQAKIECLQGD HHHHHHHHHHHHHCC | 26.52 | - | |
400 | Ubiquitination | QDLQDQLKRSEAEKL HHHHHHHHHHHHHHH | 48.52 | - | |
406 | Ubiquitination | LKRSEAEKLTLVTRV HHHHHHHHHHHHHHH | 54.54 | - | |
445 | Phosphorylation | DQALPVWSPKSFPNE HHCCCCCCCCCCCCC | 23.76 | 22115753 | |
447 | Ubiquitination | ALPVWSPKSFPNEVE CCCCCCCCCCCCCCC | 60.25 | - | |
448 | Phosphorylation | LPVWSPKSFPNEVEP CCCCCCCCCCCCCCC | 49.69 | 26074081 | |
462 | Ubiquitination | PEGTGKEKDWDLRDQ CCCCCCCCCCCHHHH | 68.55 | - | |
472 | Ubiquitination | DLRDQLQKKTLQLQA CHHHHHHHHHHHHHH | 57.21 | - | |
473 | Ubiquitination | LRDQLQKKTLQLQAK HHHHHHHHHHHHHHH | 41.32 | - | |
480 | Ubiquitination | KTLQLQAKEKECREL HHHHHHHHHHHHHHH | 57.25 | - | |
498 | Phosphorylation | LDNLSDEYLSCLRKL HHHCCHHHHHHHHHH | 14.65 | 27642862 | |
500 | Phosphorylation | NLSDEYLSCLRKLQH HCCHHHHHHHHHHHH | 15.37 | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of T3JAM_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of T3JAM_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of T3JAM_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Ubiquitylation | |
Reference | PubMed |
"The proteomic reactor facilitates the analysis of affinity-purifiedproteins by mass spectrometry: application for identifyingubiquitinated proteins in human cells."; Vasilescu J., Zweitzig D.R., Denis N.J., Smith J.C., Ethier M.,Haines D.S., Figeys D.; J. Proteome Res. 6:298-305(2007). Cited for: UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-267, AND MASSSPECTROMETRY. |